APA (7th ed.) Citation

Bode, D., Semmler, L., Wakula, P., Hegemann, N., Primessnig, U., Beindorff, N., . . . Hohendanner, F. (2021). Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF. Cardiovascular Diabetology, 20(1), 1. https://doi.org/10.1186/s12933-020-01208-z

Chicago Style (17th ed.) Citation

Bode, David, et al. "Dual SGLT-1 and SGLT-2 Inhibition Improves Left Atrial Dysfunction in HFpEF." Cardiovascular Diabetology 20, no. 1 (2021): 1. https://doi.org/10.1186/s12933-020-01208-z.

MLA (9th ed.) Citation

Bode, David, et al. "Dual SGLT-1 and SGLT-2 Inhibition Improves Left Atrial Dysfunction in HFpEF." Cardiovascular Diabetology, vol. 20, no. 1, 2021, p. 1, https://doi.org/10.1186/s12933-020-01208-z.